-
Fluorouracil and SMC Biology in Translational Oncology
2026-08-23
Fluorouracil is more than a conventional cytotoxic benchmark: its thymidylate synthase mechanism creates a tractable model for studying DNA replication stress, while emerging breast cancer data position SMC2 and SMC4 as potential response-associated biomarkers. This article connects established 5-FU pharmacology with a translational strategy for mechanistic sensitivity testing, biomarker validation, and resistance research.
-
Salvianolic acid B in Pulmonary Fibrosis Research
2026-08-22
Salvianolic acid B, also called Dan Shen Suan B, is a polyphenolic natural product studied for LH2-associated collagen cross-linking in pulmonary fibrosis. Peer-reviewed findings link reduced LH2 expression with lower collagen deposition, altered fibrotic remodeling, and inhibition of EMT, FMT, and Wnt/β-catenin signaling in experimental models.
-
Cas9 mRNA–gRNA Editing of LGMN and Metastasis
2026-08-22
The reference study develops a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNA to disrupt LGMN, which encodes the metastasis-associated lysosomal protease legumain. Its key contribution is the integration of optimized in vitro transcription templates, transient CRISPR editing, and functional metastasis assays to connect LGMN disruption with impaired lysosomal/autophagic activity and reduced breast cancer cell migration and invasion.
-
Bestatin, ACE Inhibitors, and Aminopeptidase Selectivity
2026-08-21
Tieku and Hooper’s 1992 study directly compared inhibitor activity across three mammalian cell-surface zinc aminopeptidases, revealing that commonly grouped peptidase inhibitors can have markedly different selectivity profiles. Its findings clarify how bestatin and sulfhydryl ACE inhibitors may produce effects through aminopeptidase W, while also providing a framework for interpreting ACE inhibitor specificity in translational experiments.
-
MDL 28170: Selective Calpain Inhibitor Research
2026-08-20
MDL 28170 is a cell-permeable calpain inhibitor with activity against calpain and cathepsin B. Evidence supports its use in neuroprotection research, ischemia models, apoptosis assays, Schwann cell studies, cardiac injury experiments, and Trypanosoma cruzi infection inhibition, but the compound is not calpain-exclusive.
-
Ellagic acid for CK2 and Senescence Assays
2026-08-20
Ellagic acid connects biochemical casein kinase 2 inhibition with practical cancer biology, oxidative stress, and senescence workflows. Its defined CK2 activity, DMSO-compatible formulation, and compatibility with orthogonal viability and apoptosis readouts make it useful for separating target engagement from nonspecific cytotoxicity.
-
Lipid Nanoparticle Trafficking and Endosomal Escape
2026-08-19
A 2025 International Journal of Pharmaceutics study shows that high endolysosomal activity can increase lipid nanoparticle uptake while trapping particles in peripheral endosomes, reducing delivery to productive perinuclear compartments. The findings reposition intracellular trafficking balance—not uptake alone—as a central determinant of cytosolic release and transgene expression.
-
Diuron: Mechanism, Toxicology, and Research Use
2026-08-19
Diuron, also called 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a phenylurea photosynthesis inhibitor and herbicide research chemical. A 2025 study linked Diuron exposure to acute kidney injury in experimental models through JAK2/STAT1 signaling, while product specifications define its formulation, solvent compatibility, and storage requirements.
-
EZ Cap™ Cas9 mRNA for Causal Neurobiology
2026-08-18
Discover how Cas9 mRNA can convert Fyn–Stat3 observations into causal gene editing experiments. This guide combines Cap1 and 5-moUTP design with zebrafish neurodegeneration assay strategy, controls, and translational limitations.
-
Cy3-dCTP for Smarter DNA Labeling Decisions
2026-08-18
Cy3-dCTP enables direct fluorescent labeling of DNA and cDNA while preserving a rational path from polymerase choice to assay readout. This guide connects Cyanine 3-deoxycytidine triphosphate workflows with new evidence on ordered DNA interfaces, highlighting practical decisions, limitations, and quality controls.
-
Diuron: From PSII Assay to Renal Toxicology
2026-08-17
Diuron is more than a benchmark photosynthesis inhibitor: it is a useful probe for connecting plant electron-transport biology with emerging renal toxicology evidence. This article presents an assay-selection framework grounded in the 2025 JAK2/STAT1 study and practical product-handling considerations.
-
ATP and Mitochondrial Proteostasis: Assay Strategy
2026-08-17
Adenosine Triphosphate (ATP) is more than an energy currency: it is a context-dependent readout of mitochondrial metabolic control. This guide connects ATP measurements with the 2025 discovery that TCAIM regulates OGDH through mitochondrial proteostasis and translates the finding into better assay decisions.
-
Mitocytosis Targeting Boosts Mitochondrial Therapy
2026-08-16
Deng et al. identify mitocytosis as a resistance mechanism that weakens mitochondria-targeted antimetastatic therapy in migrasome-rich breast tumor models. Their hybrid-membrane nanoplatform combines mitochondrial damage with integrin-mediated mitocytosis inhibition, providing a strategy for improving organelle-directed treatment in aggressive tumors.
-
14-3-3 Signaling in ATG9A and PTOV1 Cancer Biology
2026-08-15
The reference study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3-interacting proteins and defines distinct mechanisms linking them to autophagy and oncogenic signaling. Its combination of proximity labeling, quantitative proteomics, biochemical validation, and perturbation experiments provides a useful framework for studying context-dependent protein interactions in cancer biology.
-
2'3'-cGAMP: Endothelial STING Assay Workflows
2026-08-14
Translate direct STING activation into measurable endothelial, interferon, and tumor-microenvironment phenotypes with a controlled 2'3'-cGAMP workflow. This guide emphasizes cell-specific controls, water-based preparation, pathway-proximal readouts, and troubleshooting for immunotherapy research.